Vitter Questions FEMA on Alleged Slow-Walking of Nuclear Plant Safety Reviews

Targeted News Service |

WASHINGTON, June 24 -- The ranking Republican member of the Senate Environment and Public Works Committee issued the following news release: Today, U.S. Sen. David Vitter (R-La.), top Republican on the Environment and Public Works Committee, sent a letter to William Craig Fugate, Administrator of the Federal Emergency Management Agency (FEMA), regarding allegations that the Agency may not be fulfilling its obligations to support the Nuclear Regulatory Commission (NRC) in timely reviewing the safety requirements for decommissioning nuclear power plants. "Any attempt for federal agencies to circumvent their mandated responsibilities is unacceptable, especially when their actions, or lack thereof, affect a crucial portion of our nation's energy production and unfairly prejudice rate payers and utility owners," said Vitter. "I urge FEMA to continue reviewing exemption requests in a timely manner so that the NRC can move forward with safety and security decisions for decommissioning reactors." Recently, Vitter obtained new information alleging that FEMA has delayed evaluations of one or more exemption requests by licensees who are in the process of permanently shutting down nuclear plants, likely as a result of unofficial requests by congressional staff members. In the letter, Vitter requests correspondence and records between FEMA, NRC, and congressional offices related to exemption requests. Click here to read today's letter (http://1.usa.gov/1pKIDAz). TNS 30FurigayJof-140625-4777557 30FurigayJof

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
STKAF Stockland Stapled Sec 3.61 0.00 0.00 0

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…